Docality.com Logo
 
Dr. Kaushik  Kundu  Md image

Dr. Kaushik Kundu Md

1130 Delaware Ave
Fountain Hill PA 18015
610 682-2710
Medical School: Other - 1988
Accepts Medicare: Yes
Participates In eRX: Yes
Participates In PQRS: No
Participates In EHR: No
License #: MD062852L
NPI: 1942259577
Taxonomy Codes:
207R00000X

Request Appointment Information

Awards & Recognitions

About Us

Practice Philosophy

Conditions

Dr. Kaushik Kundu is associated with these group practices

Procedure Pricing

HCPCS Code Description Average Price Average Price
Allowed By Medicare
HCPCS Code:99223 Description:Initial hospital care Average Price:$240.00 Average Price Allowed
By Medicare:
$189.96
HCPCS Code:99222 Description:Initial hospital care Average Price:$175.00 Average Price Allowed
By Medicare:
$129.50
HCPCS Code:99238 Description:Hospital discharge day Average Price:$100.00 Average Price Allowed
By Medicare:
$67.32
HCPCS Code:93000 Description:Electrocardiogram complete Average Price:$45.00 Average Price Allowed
By Medicare:
$17.87
HCPCS Code:99335 Description:Domicil/r-home visit est pat Average Price:$110.00 Average Price Allowed
By Medicare:
$88.20
HCPCS Code:99214 Description:Office/outpatient visit est Average Price:$120.00 Average Price Allowed
By Medicare:
$99.25
HCPCS Code:99334 Description:Domicil/r-home visit est pat Average Price:$75.00 Average Price Allowed
By Medicare:
$56.55
HCPCS Code:99213 Description:Office/outpatient visit est Average Price:$85.00 Average Price Allowed
By Medicare:
$67.02
HCPCS Code:99232 Description:Subsequent hospital care Average Price:$85.00 Average Price Allowed
By Medicare:
$67.71
HCPCS Code:81002 Description:Urinalysis nonauto w/o scope Average Price:$20.00 Average Price Allowed
By Medicare:
$3.62
HCPCS Code:Q2038 Description:Fluzone vacc, 3 yrs & >, im Average Price:$25.00 Average Price Allowed
By Medicare:
$12.96
HCPCS Code:90732 Description:Pneumococcal vaccine Average Price:$75.25 Average Price Allowed
By Medicare:
$64.02
HCPCS Code:Q2037 Description:Fluvirin vacc, 3 yrs & >, im Average Price:$25.00 Average Price Allowed
By Medicare:
$14.05
HCPCS Code:J1040 Description:Methylprednisolone 80 MG inj Average Price:$15.00 Average Price Allowed
By Medicare:
$6.66
HCPCS Code:96372 Description:Ther/proph/diag inj sc/im Average Price:$30.00 Average Price Allowed
By Medicare:
$22.41
HCPCS Code:G0009 Description:Admin pneumococcal vaccine Average Price:$25.00 Average Price Allowed
By Medicare:
$22.64
HCPCS Code:G0008 Description:Admin influenza virus vac Average Price:$25.00 Average Price Allowed
By Medicare:
$22.64

HCPCS Code Definitions

G0009
Administration of pneumococcal vaccine
J1040
Injection, methylprednisolone acetate, 80 mg
99335
Domiciliary or rest home visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 25 minutes are spent with the patient and/or family or caregiver.
Q2038
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)
96372
Therapeutic, prophylactic, or diagnostic injection (specify substance or drug); subcutaneous or intramuscular
99213
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: An expanded problem focused history; An expanded problem focused examination; Medical decision making of low complexity. Counseling and coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of low to moderate severity. Typically, 15 minutes are spent face-to-face with the patient and/or family.
Q2037
Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)
99223
Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of high complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of high severity. Typically, 70 minutes are spent at the bedside and on the patient's hospital floor or unit.
99232
Subsequent hospital care, per day, for the evaluation and management of a patient, which requires at least 2 of these 3 key components: An expanded problem focused interval history; An expanded problem focused examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the patient is responding inadequately to therapy or has developed a minor complication. Typically, 25 minutes are spent at the bedside and on the patient's hospital floor or unit.
99222
Initial hospital care, per day, for the evaluation and management of a patient, which requires these 3 key components: A comprehensive history; A comprehensive examination; and Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the problem(s) requiring admission are of moderate severity. Typically, 50 minutes are spent at the bedside and on the patient's hospital floor or unit.
G0008
Administration of influenza virus vaccine
99214
Office or other outpatient visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A detailed history; A detailed examination; Medical decision making of moderate complexity. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are of moderate to high severity. Typically, 25 minutes are spent face-to-face with the patient and/or family.
99334
Domiciliary or rest home visit for the evaluation and management of an established patient, which requires at least 2 of these 3 key components: A problem focused interval history; A problem focused examination; Straightforward medical decision making. Counseling and/or coordination of care with other physicians, other qualified health care professionals, or agencies are provided consistent with the nature of the problem(s) and the patient's and/or family's needs. Usually, the presenting problem(s) are self-limited or minor. Typically, 15 minutes are spent with the patient and/or family or caregiver.
99238
Hospital discharge day management; 30 minutes or less
93000
Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report

Medical Malpractice Cases

None Found

Medical Board Sanctions

None Found

Referrals

NPI
Doctor Name
Specialty
Count
1497752182
Cardiovascular Disease (Cardiology)
1,132
1477523793
Urology
865
1104910660
Cardiovascular Disease (Cardiology)
813
1780620492
Ophthalmology
616
1922053388
Psychiatry
576
1568557965
Cardiovascular Disease (Cardiology)
523
1790714111
Diagnostic Radiology
460
1427012632
Urology
442
1699702258
Diagnostic Radiology
441
1770551616
Diagnostic Radiology
423
*These referrals represent the top 10 that Dr. Kundu has made to other doctors

Publications

Formation, thermodynamic properties, microstructures and antimicrobial activity of mixed cationic/non-ionic surfactant microemulsions with isopropyl myristate as oil. - Journal of colloid and interface science
Modification of the interface by blending of surfactants produces considerable changes in the elastic rigidity of the interface, which in turn affects the physicochemical properties of w/o microemulsions. Hence, it could be possible to tune the thermodynamic properties, microstructures and antimicrobial activity of microemulsions by using ionic/non-ionic mixed surfactants and polar lipophilic oil, which are widely used in biologically relevant systems.The present report was aimed at precise characterization of mixed cetyltrimethylammonium bromide and polyoxyethylene (23) lauryl ether microemulsions stabilized in 1-pentanol (Pn) and isopropyl myristate at different physicochemical conditions by employing phase studies, the dilution method, conductivity, DLS, FTIR (with HOD probing) and (1)H NMR measurements. Further, microbiological activities at different compositions were examined against two bacterial strains Bacillus subtilis and Escherichia coli at 303 K.The formation of mixed surfactant microemulsions was found to be spontaneous at all compositions, whereas it was endothermic at equimolar composition. FTIR and (1)H NMR measurements showed the existence of bulk-like, bound and trapped water molecules in confined environments. Interestingly, composition dependence of both highest and lowest inhibitory effects was observed against the bacterial strains, whereas similar features in spontaneity of microemulsion formation were also evidenced. These results suggested a close relationship between thermodynamic stability and antimicrobial activities. Such studies on polar lipophilic oil derived mixed surfactant microemulsions have not been reported earlier.Copyright © 2014 Elsevier Inc. All rights reserved.
Physicochemical investigation of mixed surfactant microemulsions: water solubilization, thermodynamic properties, microstructure, and dynamics. - Journal of colloid and interface science
In this contribution, we report on a systematic investigation of phase behavior and solubilization of water in water-in-heptane or decane aggregates stabilized by mixtures of polyoxyethylene (20) cetyl ether (Brij-58) and cetyltrimethylammonium bromide (CTAB) surfactants with varying compositions in conjugation with 1-pentanol (Pn) at fixed surfactant(s)/Pn ratio and temperature. Synergism in water solubilization was evidenced by the addition of CTAB to Brij-58 stabilized system in close proximity of equimolar composition in both oils. An attempt has been made to correlate composition dependent water solubilization and volume induced conductivity studies to provide insight into the solubilization mechanism of these mixed systems. Conductivity studies reveal the ascending curve in water solubilization capacity-(Brij-58:CTAB, w/w) profile as the interdroplet interaction branch indicating percolation of conductance and the descending curve is a curvature branch due to the rigidity of the interface in these systems. The microstructure of these systems as a function of surfactant composition has been determined by dynamic light scattering (DLS) and Fourier transform infrared spectroscopy (FTIR) measurements. FTIR study reveals increase and decrease in relative population of bound and bulk-like water, respectively, with increase in Brij-58:CTAB (w/w). DLS measurements showed that the droplet hydrodynamic diameter (Dh) decreases significantly with the increase in Brij-58:CTAB (w/w). Further, the interfacial composition and energetic parameters for the transfer of Pn from bulk oil to the interface were evaluated by the dilution method. Formation of temperature-insensitive microemulsions and temperature invariant droplet sizes are evidenced in the vicinity of the equimolar composition. The results are interpreted in terms of a proposed mechanism.Copyright © 2013 Elsevier Inc. All rights reserved.
Physicochemical studies of mixed surfactant microemulsions with isopropyl myristate as oil. - Journal of colloid and interface science
The present study is focused on evaluation of interfacial compositions and thermodynamic properties of w/o mixed surfactant [(sodium dodecylsulfate, SDS/polyoxyethylene (23) lauryl ether, Brij-35)/1-pentanol (Pn)/isopropyl myristate (IPM)] microemulsions under various physicochemical conditions by the dilution method. The number of moles of Pn at the interface (n(a)(i)) and bulk oil (n(a)(o)), and various thermodynamic parameters [viz. standard Gibbs free energy (ΔG(o→i)(0)), standard enthalpy (ΔH(o→i)(0)), and standard entropy (ΔS(o→i)(0)) of the transfer of Pn from bulk oil to the interface] have been found to be dependent on the molar ratio of water to surfactant (ω), concentration of Brij-35 (X(Brij-35)), and temperature. Temperature-insensitive microemulsions with zero specific heat capacity (ΔC(p)(0))(o→i) have been formed at specific compositions. The intrinsic enthalpy change of the transfer process (ΔH(0))(o→i)* has been evaluated from linear correlation between ΔH(o→i)(0) and ΔS(o→i)(0) at different experimental temperatures. The present report also aims at a precise characterization on the basis of molecular interactions between the constituents and provides insight into the nature of the oil/water interfaces of these systems by conductivity and dynamic light scattering studies as a function of ω and X(Brij-35). Conductivity studies reveal that incorporation of Brij-35 in non-percolating water/SDS/Pn/IPM systems makes them favorable for ω-induced percolation behavior up to X(Brij-35) ≤ 0.5. But further addition of Brij-35 causes a decrease in conductivity with increasing ω. Furthermore, the hydrodynamic diameters of the microemulsion droplets increase with increase in both X(Brij-35) and ω. Correlations of the results in terms of the evaluated physicochemical parameters have been attempted.Copyright © 2013 Elsevier Inc. All rights reserved.
Interfacial composition, thermodynamic properties, and structural parameters of water-in-oil microemulsions stabilized by 1-pentanol and mixed surfactants. - Journal of colloid and interface science
The present study is focused on the evaluation of the interfacial composition, thermodynamic properties, and structural parameters of water-in-oil mixed surfactant microemulsions [(cetylpyridinium chloride, CPC+polyoxyethylene (20) cetyl ether, Brij-58 or polyoxyethylene (20) stearyl ether, Brij-78)/1-pentanol/n-heptane, or n-decane] under various physicochemical environments by the Schulman method of cosurfactant titration of the oil/water interface. The estimation of the number of moles of 1-pentanol at the interface (n(a)(i)) and bulk oil (n(a)(o)) and its distribution between these two domains at the threshold level of stability have been emphasized. The thermodynamics of transfer of 1-pentanol from the continuous oil phase to the interface have been evaluated. n(a)(i),n(a)(i), standard Gibbs free energy (ΔG(t)(0)), standard enthalpy (ΔH(t)(0)), and standard entropy (ΔG(t)(0)) of transfer process have been found to be dependent on the molar ratio of water to surfactant (ω), type of nonionic surfactant and its content (X(Brij-58 or Brij-78)), oil and temperature. A correlation between (ΔH(t)(0)) and (ΔS(t)(0)) is examined at different experimental temperatures. Bulk surfactant composition dependent temperature insensitive microemulsions have been reported. Associated structural parameters, such as droplet dimensions and aggregation number of surfactant and cosurfactant at the droplet interface have been evaluated using a mathematical model after suitable modifications for mixed surfactant systems. In light of these parameters, the prospect of using these microemulsion systems for the synthesis of nanoparticles and the modulation of enzyme activity has been discussed. Correlations of the results in terms of the evaluated physicochemical parameters have been attempted.Copyright © 2012 Elsevier Inc. All rights reserved.

Map & Directions

1130 Delaware Ave Fountain Hill, PA 18015
View Directions In Google Maps

Nearby Doctors

801 Ostrum St Dept. Of Emergency Medicine
Bethlehem, PA 18015
610 544-4903
240 Union Station Plz
Bethlehem, PA 18015
610 542-2868
801 Ostrum St Department Of Internal Medicine
Bethlehem, PA 18015
610 544-4644
240 Union Station Plz Dr. Hadi Ghazzouli-Dental Clinic
Bethlehem, PA 18015
215 806-6067
11 W 2Nd St Apt 232
Bethlehem, PA 18015
917 879-9463
801 Ostrum St
Bethlehem, PA 18015
484 264-4000
801 Ostrum St
Bethlehem, PA 18015
484 264-4000
240 Union Station Plz
Bethlehem, PA 18015
610 542-2465
1130 Delaware Ave
Fountain Hill, PA 18015
610 682-2710
801 Ostrum St
Bethlehem, PA 18015
484 264-4761